IL131160A0 - 5-Aminoalkoxy-1,4-dihydroquinoxaline-2,3-diones being dopamine agonists - Google Patents

5-Aminoalkoxy-1,4-dihydroquinoxaline-2,3-diones being dopamine agonists

Info

Publication number
IL131160A0
IL131160A0 IL13116098A IL13116098A IL131160A0 IL 131160 A0 IL131160 A0 IL 131160A0 IL 13116098 A IL13116098 A IL 13116098A IL 13116098 A IL13116098 A IL 13116098A IL 131160 A0 IL131160 A0 IL 131160A0
Authority
IL
Israel
Prior art keywords
dihydroquinoxaline
aminoalkoxy
diones
dopamine agonists
dopamine
Prior art date
Application number
IL13116098A
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of IL131160A0 publication Critical patent/IL131160A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40Benzopyrazines
    • C07D241/44Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
IL13116098A 1997-02-18 1998-01-13 5-Aminoalkoxy-1,4-dihydroquinoxaline-2,3-diones being dopamine agonists IL131160A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80132497A 1997-02-18 1997-02-18
PCT/US1998/001170 WO1998035948A1 (en) 1997-02-18 1998-01-13 5-aminoalkoxy-1,4-dihydroquinoxaline-2,3-diones being dopamine agonists

Publications (1)

Publication Number Publication Date
IL131160A0 true IL131160A0 (en) 2001-01-28

Family

ID=25180799

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13116098A IL131160A0 (en) 1997-02-18 1998-01-13 5-Aminoalkoxy-1,4-dihydroquinoxaline-2,3-diones being dopamine agonists

Country Status (14)

Country Link
EP (1) EP0963372A1 (en)
JP (1) JP2001511805A (en)
KR (1) KR20000071162A (en)
CN (1) CN1248249A (en)
AR (1) AR011669A1 (en)
AU (1) AU722616B2 (en)
BR (1) BR9807230A (en)
CA (1) CA2278757A1 (en)
HU (1) HUP0001311A3 (en)
IL (1) IL131160A0 (en)
NZ (1) NZ336971A (en)
TW (1) TW434230B (en)
WO (1) WO1998035948A1 (en)
ZA (1) ZA981306B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101641391B1 (en) 2008-06-16 2016-07-20 메르크 파텐트 게엠베하 Quinoxalinedione derivatives

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO179551C (en) * 1987-11-10 1996-10-30 Novo Nordisk As Analogous Process for Preparing Therapeutically Effective Quinoxaline Compounds
DK715888D0 (en) * 1988-12-22 1988-12-22 Ferrosan As QUINOXAL COMPOUNDS, THEIR PREPARATION AND USE
US4975430A (en) * 1989-06-16 1990-12-04 The State Of Oregon Acting By And Through The State Board Of Education On Behalf Of The Oregon Health Sciences University CNQX and its analogs as therapeutics for degenerative neural diseases
PT99864B (en) * 1990-12-21 1999-06-30 Schering Ag METHOD FOR PREPARING NEW PHARMACEUTICAL COMPOSITIONS CONTAINING QUISQUALATE RECEPTOR ANTAGONISTS
US5159083A (en) * 1990-12-28 1992-10-27 Neurogen Corporation Certain aminomethyl phenylimidazole derivatives; a class of dopamine receptor subtype specific ligands
DE69334237D1 (en) * 1992-06-22 2008-09-25 State Of Oregon Through Oregon GLYCINE RECEPTOR ANTAGONISTS AND THEIR USE
GB9419318D0 (en) * 1994-09-24 1994-11-09 Pfizer Ltd Therapeutic agents
ES2169102T3 (en) * 1994-10-14 2002-07-01 Merck Patent Gmbh (R) - (-) - 2- (5- (4-FLUORFENIL) -3-PIRIDILMETILAMINOMETIL) -CROMANO AS ACTIVE AGENT ON THE CENTRAL NERVOUS SYSTEM.
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists

Also Published As

Publication number Publication date
AU6035098A (en) 1998-09-08
WO1998035948A1 (en) 1998-08-20
TW434230B (en) 2001-05-16
HUP0001311A2 (en) 2001-05-28
ZA981306B (en) 1999-08-17
JP2001511805A (en) 2001-08-14
HUP0001311A3 (en) 2001-07-30
BR9807230A (en) 2000-04-25
AR011669A1 (en) 2000-08-30
KR20000071162A (en) 2000-11-25
NZ336971A (en) 2000-10-27
CA2278757A1 (en) 1998-08-20
AU722616B2 (en) 2000-08-10
CN1248249A (en) 2000-03-22
EP0963372A1 (en) 1999-12-15

Similar Documents

Publication Publication Date Title
ZA989230B (en) Prostaglandin agonists.
ZA200100900B (en) 2-substituted-1-piperidyl benzimidazole compounds as orl1-receptor agonists.
ZA986784B (en) Tricyclic vasopressin agonists.
ZA9811959B (en) Ibuprofen composition.
DE59812367D1 (en) 2-arylcyclopentan-1,3-dione
AU5203999A (en) Beta3-adrenergic receptor agonists
ZA200203450B (en) beta2-adrenergic receptor agonists.
ZA987057B (en) 2-benzoylcyclohexane-1,3-diones.
ZA991272B (en) Novel thiobenzamides.
ZA9811026B (en) Selective B3 adrenergic agonists.
ZA987056B (en) 2-benzoylcyclohexane-1,3-diones.
ZA988B (en) 3-aminocarbonyl-/3-aminothiocarbonyl-substituted 2-benzoylcyclohexane-1,3-diones.
ZA992899B (en) Novel compound.
PL334473A1 (en) Substituted 2-benzoylcyclohexano-1,3-diones
ZA996913B (en) Tetrahydronaphthalenes.
IL131160A0 (en) 5-Aminoalkoxy-1,4-dihydroquinoxaline-2,3-diones being dopamine agonists
ZA991893B (en) 5-Heteroaryl substituted indoles.
ZA995029B (en) Estrogen agonists/antagonists.
GB9810998D0 (en) Antitumour 1,5-diazaanthraquinones
PL336807A1 (en) Substituted 2-(3-alkenylbenzoyl)cyclohexane-1,3-diones
ZA981310B (en) 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one dopamine autoreceptor agonists.
PL336794A1 (en) Substituted 2-benzoylcyclohexane-1,3-diones
AU4263999A (en) Substituted 1,3-diaza-2-(thi)oxo-cycloalkanes
ZA991761B (en) New agent.
ZA991492B (en) Label holder.